The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fc Fusion Protein Market Research Report 2025
Synopsis
Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
This report will focus on Fc fusion protein drugs.
The global Fc Fusion Protein market was valued at US$ 29470 million in 2023 and is anticipated to reach US$ 60530 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.
This report aims to provide a comprehensive presentation of the global market for Fc Fusion Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fc Fusion Protein.
Report Scope
The Fc Fusion Protein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fc Fusion Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fc Fusion Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fc Fusion Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fc Fusion Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
This report will focus on Fc fusion protein drugs.
The global Fc Fusion Protein market was valued at US$ 29470 million in 2023 and is anticipated to reach US$ 60530 million by 2030, witnessing a CAGR of 10.7% during the forecast period 2024-2030.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.
This report aims to provide a comprehensive presentation of the global market for Fc Fusion Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fc Fusion Protein.
Report Scope
The Fc Fusion Protein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fc Fusion Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fc Fusion Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fc Fusion Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fc Fusion Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fc Fusion Protein Market Overview
1.1 Product Overview and Scope of Fc Fusion Protein
1.2 Fc Fusion Protein Segment by Type
1.2.1 Global Fc Fusion Protein Market Value Comparison by Type (2024-2030)
1.2.2 Brands Drugs
1.2.3 Biosimilar Drugs
1.3 Fc Fusion Protein Segment by Application
1.3.1 Global Fc Fusion Protein Market Value by Application: (2024-2030)
1.3.2 Autoimmune Disease
1.3.3 Eye Diseases
1.3.4 Diabetes
1.3.5 Hemophilia
1.4 Global Fc Fusion Protein Market Size Estimates and Forecasts
1.4.1 Global Fc Fusion Protein Revenue 2019-2030
1.4.2 Global Fc Fusion Protein Sales 2019-2030
1.4.3 Global Fc Fusion Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fc Fusion Protein Market Competition by Manufacturers
2.1 Global Fc Fusion Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fc Fusion Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fc Fusion Protein Average Price by Manufacturers (2019-2024)
2.4 Global Fc Fusion Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fc Fusion Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fc Fusion Protein, Product Type & Application
2.7 Fc Fusion Protein Market Competitive Situation and Trends
2.7.1 Fc Fusion Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fc Fusion Protein Players Market Share by Revenue
2.7.3 Global Fc Fusion Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fc Fusion Protein Retrospective Market Scenario by Region
3.1 Global Fc Fusion Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fc Fusion Protein Global Fc Fusion Protein Sales by Region: 2019-2030
3.2.1 Global Fc Fusion Protein Sales by Region: 2019-2024
3.2.2 Global Fc Fusion Protein Sales by Region: 2025-2030
3.3 Global Fc Fusion Protein Global Fc Fusion Protein Revenue by Region: 2019-2030
3.3.1 Global Fc Fusion Protein Revenue by Region: 2019-2024
3.3.2 Global Fc Fusion Protein Revenue by Region: 2025-2030
3.4 North America Fc Fusion Protein Market Facts & Figures by Country
3.4.1 North America Fc Fusion Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fc Fusion Protein Sales by Country (2019-2030)
3.4.3 North America Fc Fusion Protein Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fc Fusion Protein Market Facts & Figures by Country
3.5.1 Europe Fc Fusion Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fc Fusion Protein Sales by Country (2019-2030)
3.5.3 Europe Fc Fusion Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fc Fusion Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Fc Fusion Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fc Fusion Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific Fc Fusion Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fc Fusion Protein Market Facts & Figures by Country
3.7.1 Latin America Fc Fusion Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fc Fusion Protein Sales by Country (2019-2030)
3.7.3 Latin America Fc Fusion Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fc Fusion Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Fc Fusion Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fc Fusion Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fc Fusion Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fc Fusion Protein Sales by Type (2019-2030)
4.1.1 Global Fc Fusion Protein Sales by Type (2019-2024)
4.1.2 Global Fc Fusion Protein Sales by Type (2025-2030)
4.1.3 Global Fc Fusion Protein Sales Market Share by Type (2019-2030)
4.2 Global Fc Fusion Protein Revenue by Type (2019-2030)
4.2.1 Global Fc Fusion Protein Revenue by Type (2019-2024)
4.2.2 Global Fc Fusion Protein Revenue by Type (2025-2030)
4.2.3 Global Fc Fusion Protein Revenue Market Share by Type (2019-2030)
4.3 Global Fc Fusion Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fc Fusion Protein Sales by Application (2019-2030)
5.1.1 Global Fc Fusion Protein Sales by Application (2019-2024)
5.1.2 Global Fc Fusion Protein Sales by Application (2025-2030)
5.1.3 Global Fc Fusion Protein Sales Market Share by Application (2019-2030)
5.2 Global Fc Fusion Protein Revenue by Application (2019-2030)
5.2.1 Global Fc Fusion Protein Revenue by Application (2019-2024)
5.2.2 Global Fc Fusion Protein Revenue by Application (2025-2030)
5.2.3 Global Fc Fusion Protein Revenue Market Share by Application (2019-2030)
5.3 Global Fc Fusion Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Fc Fusion Protein Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Fc Fusion Protein Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Regeneron
6.3.1 Regeneron Corporation Information
6.3.2 Regeneron Description and Business Overview
6.3.3 Regeneron Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Regeneron Fc Fusion Protein Product Portfolio
6.3.5 Regeneron Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Fc Fusion Protein Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Fc Fusion Protein Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Fc Fusion Protein Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly and Company Fc Fusion Protein Product Portfolio
6.7.5 Eli Lilly and Company Recent Developments/Updates
6.8 Sobi
6.8.1 Sobi Corporation Information
6.8.2 Sobi Description and Business Overview
6.8.3 Sobi Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sobi Fc Fusion Protein Product Portfolio
6.8.5 Sobi Recent Developments/Updates
6.9 Kanghong Pharma
6.9.1 Kanghong Pharma Corporation Information
6.9.2 Kanghong Pharma Description and Business Overview
6.9.3 Kanghong Pharma Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kanghong Pharma Fc Fusion Protein Product Portfolio
6.9.5 Kanghong Pharma Recent Developments/Updates
6.10 3SBIO
6.10.1 3SBIO Corporation Information
6.10.2 3SBIO Description and Business Overview
6.10.3 3SBIO Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 3SBIO Fc Fusion Protein Product Portfolio
6.10.5 3SBIO Recent Developments/Updates
6.11 Celgen Biopharma
6.11.1 Celgen Biopharma Corporation Information
6.11.2 Celgen Biopharma Fc Fusion Protein Description and Business Overview
6.11.3 Celgen Biopharma Fc Fusion Protein Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Celgen Biopharma Fc Fusion Protein Product Portfolio
6.11.5 Celgen Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fc Fusion Protein Industry Chain Analysis
7.2 Fc Fusion Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fc Fusion Protein Production Mode & Process
7.4 Fc Fusion Protein Sales and Marketing
7.4.1 Fc Fusion Protein Sales Channels
7.4.2 Fc Fusion Protein Distributors
7.5 Fc Fusion Protein Customers
8 Fc Fusion Protein Market Dynamics
8.1 Fc Fusion Protein Industry Trends
8.2 Fc Fusion Protein Market Drivers
8.3 Fc Fusion Protein Market Challenges
8.4 Fc Fusion Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
